MobiHealthNews

EMR-based algorithm identifies patients at risk of serious cancer therapy side effects

Researchers at Peter MacCallum Cancer Centre have developed a digital phenotype to assist with automatically identifying ...
Everyday Health

Do People With Ulcerative Colitis Have an Increased Suicide Risk?

In one review of 28 studies that included more than one million people with IBD, researchers found they were also four times more likely to consider suicide than the general population. Another study ...
Dhaka Tribune

Colorectal cancer rising rapidly among younger adults

Once regarded as a disease affecting people over the age of 50, colorectal cancer is now rising at an alarming rate among ...
MedPage Today on MSN

Bowel Disease, GLP-1s, and Colon Cancer; Herbs for MASLD? Managing Bile Duct Stones

News and commentary from the world of gastroenterology and hepatology ...
Le Lézard

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

AbbVie today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of upadacitinib (RINVOQ®; 15 ...
Medscape

Prescription Acid Suppressants in Pregnancy Not Linked to GI Disease in Children

The study, published in JAMA Network Open, found the relative risk for inflammatory bowel disease (IBD) was about 8% higher in kids whose mothers took prescription proton pump inhibitors (PPI) or H2 ...

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) has approved SKYRIZI® (risankizumab) for the treatment of children ...

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with ...
Phys.org

Saturday Citations: JAXA collaboration with toy company TOMY; a new brain-computer interface; IBD solved

This week's notable citations: Astronomers believe collapsing stars could spawn mini universes. Chimpanzees do not like unfairness. And a single dose of psilocybin temporarily restored function in an ...
Medindia

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
BioSpace

U.S. FDA Accepts Takeda’s Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn’s Disease

If approved, ENTYVIO would be the only gut-focused treatment for patients two years and older with moderately to severely active ulcerative colitis (UC) or Crohn's disease Potential for ENTYVIO to ...